# Echolight

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/echolight

- Industry: Medical Devices & Equipment
- Headquarters: Lecce, Italy
- Website: www.echolight.it
- Total disclosed funding: $4.4M
- Latest round: Series A (Jun 22, 2016)
- Investors on record: 2

## About

Echolight develops innovative medical imaging solutions focused on bone health, utilizing proprietary technology to provide rapid, radiation-free assessments for bone density and quality.Founded in 2010 in Lecce, Italy, Echolight specializes in advanced medical imaging technology for bone health assessment. The company was co-founded by Matteo Pernisa and is currently led by CEO Sergio Casciaro. It raised EUR 4 million in Series A funding in June 2016, which has been instrumental in supporting its growth initiatives. The company has a total of 1 investment deal recorded.Echolight specializes in advanced medical imaging technology for bone health assessment, primarily through its flagship product, EchoS, which utilizes proprietary R.E.M.S. (Radiofrequency Echographic Multi Spectrometry) technology. This innovative device offers a radiation-free alternative for evaluating bone density and quality in the lumbar vertebrae and proximal femur. The EchoS system enables rapid ultrasound scans that produce detailed assessments of bone health within minutes, crucial for early osteoporosis diagnosis, risk stratification, and ongoing monitoring. Targeted towards healthcare providers, the device serves a diverse patient demographic, including those at risk for osteoporosis, pediatric patients, diabetics, cancer survivors, and pregnant women. EchoS is used in various regions, including Europe, North America, and select markets in Asia and Latin America.In 2023, Echolight generated revenue of EUR 6,567,290.60 with an EBITDA of EUR 1,881,233.50. The company generates revenue through direct sales of its EchoS systems to healthcare providers and institutions, typically involving B2B transactions that ensure immediate bone health assessments for patients.Echolight plans to utilize the EUR 4 million raised in Series A funding from CDP Venture Capital and Panakes Partners to expand the adoption of its platform. The company aims to introduce new products and enhance its presence in existing markets while targeting expansion into additional geographic regions. Specific markets for future growth have yet to be detailed, but the focus will be on increasing accessibility and utilization of the EchoS technology within the healthcare sector.

## Funding rounds

- Series A, Jun 22, 2016, $4.4M — CDP Venture Capital, Panakes Partners

## Investors

- CDP Venture Capital (https://capitalatlas.ai/funds/cdp-venture-capital) — Series A
- Panakes Partners (https://capitalatlas.ai/funds/panakes-partners) — Series A